Cancer DNA methylation: molecular mechanisms and clinical implications.
about
Epigenetic modifications in cancerAberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?Epigenetic: A missing paradigm in cellular and molecular pathways of sulfur mustard lung: a prospective and comparative studyEnvironmental Epigenetics: Crossroad between Public Health, Lifestyle, and Cancer PreventionEpigenome engineering in cancer: fairytale or a realistic path to the clinic?Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse modelsEpigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancerStructural and Functional Profiling of the Human Histone Methyltransferase SMYD3Comparison of the Structural and Dynamic Effects of 5-Methylcytosine and 5-Chlorocytosine in a CpG Dinucleotide SequenceEnhanced Methylation Analysis by Recovery of Unsequenceable FragmentsLoss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesisInteraction of methylation-related genetic variants with circulating fatty acids on plasma lipids: a meta-analysis of 7 studies and methylation analysis of 3 studies in the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium.Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets.A Meta-Analysis of the Association between DNMT1 Polymorphisms and Cancer Risk.Demethylating Agents in the Treatment of CancerEpigenetic regulation of epithelial-mesenchymal transitionIdentification of DBCCR1 as a suppressor in the development of lung cancer that is associated with increased DNA methyltransferase 1.HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer.Loss of glucocorticoid receptor expression by DNA methylation prevents glucocorticoid induced apoptosis in human small cell lung cancer cellsEpigenetics and cancer.DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.Cancer biology and NuRD: a multifaceted chromatin remodelling complexEpigenetic imbalance and the floral developmental abnormality of the in vitro-regenerated oil palm Elaeis guineensis.DNA methylation analysis of bone marrow cells at diagnosis of acute lymphoblastic leukemia and at remission.Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.Immortalization of T-cells is accompanied by gradual changes in CpG methylation resulting in a profile resembling a subset of T-cell leukemias.S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer.Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinaseDNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth.Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing.Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer.RUNX3 site-specific hypermethylation predicts papillary thyroid cancer recurrence.Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth.Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area.Epigenetic and metabolic regulation of breast cancer stem cells.Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transitionSUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation.Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach.Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma.
P2860
Q22242610-D8C573B9-E072-46F7-BC3B-116A721C02B7Q26738706-CCF55139-74B6-41E5-9730-B2A8ECA8C6A1Q26777648-720121F6-76F5-4596-BABA-71C917F2652CQ26784500-70AE7849-8BE3-4DAC-9E62-2227FC16D2C7Q26861350-D59AD9A3-B922-4EAA-9EBC-6A3DD5ECD1F8Q26994661-76306DE0-100D-462D-88F9-E0920DDBDA66Q27022720-64408553-5198-4F3C-82F7-07A753C5812EQ27670941-9FD5BF47-8C5F-4205-981E-BDFF3C2C8D00Q27680423-521DF4C5-0402-46AF-BB0C-20D06E930C7DQ28551087-24DD3CAC-0302-484D-8F48-9A54F5B9D7BAQ28589092-B3C1BB42-1900-4B27-B26C-A7C2F787214AQ30277712-CDEFB483-47EA-43D1-914A-7B6DDB230A47Q30359391-1DA1A4B7-4F55-41EB-862C-B4A325840BBBQ33572091-F2924765-5A4D-4646-B9E5-2B65A064617CQ33678040-D3168556-AF5A-4523-98CC-686725EB7698Q33764436-389550C6-8D2C-4045-A0A7-AF7762BA9B31Q33779270-0B027C03-E81B-48A3-9270-0B074D7061AAQ33818402-6EC3451B-25FF-4F56-AB23-FAC8558898E6Q33915416-273F2D67-89A9-4599-B909-ED709630888FQ34044810-08F552E2-05C5-448B-A6D3-E25EF1F2E7E4Q34085532-147EEA1D-218E-4CD3-BBEF-92DFE4B02F0AQ34096524-9A8D7FE0-EA73-494D-8EAF-428494F7C894Q34148512-472C57DD-0544-4EA5-83E2-7E73536173CFQ34158453-D5EFDF4F-5E62-411E-B4E1-AA3F2E05E4FDQ34228412-23703FCC-B25A-4E2A-8B58-33EACA47A8EEQ34279875-A0DD7639-C6E9-426F-9965-0666E30E3B73Q34347248-A807AA43-CD38-4077-8077-84C681F2A61BQ34394796-268F255A-7622-4FE8-AB7B-ADB41E09EE93Q34451033-BCFBE4C9-0DD5-4433-949E-B134DFBF17F6Q34574257-BEE81CA9-BF01-46AE-A362-A380F2F65E67Q34629266-DC23AF74-6846-498C-8FA4-4D1D52E13B19Q34631368-3B0701DF-035C-47DC-AEFA-29AF2A3E87CDQ34704862-94F9659C-BEDE-4F66-9A38-9F5CF0E081E8Q34825949-B104C117-3835-40B3-9EF9-76B5D12FBDACQ34879739-F0173772-1DE1-4775-9D8D-6317003E6831Q34890549-42C39239-537D-4496-AB0F-143B97712981Q34984574-FC7DCC8D-D41D-4B49-A5F3-9E2A16C4AEA1Q35077092-6D6A5521-E330-4E24-B984-5F8BF4BC1AB6Q35136675-F44C807D-17AC-4262-9248-456B3EBE2C6DQ35169860-6984264F-92AB-4845-8606-F324854E4D8C
P2860
Cancer DNA methylation: molecular mechanisms and clinical implications.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Cancer DNA methylation: molecular mechanisms and clinical implications.
@en
Cancer DNA methylation: molecular mechanisms and clinical implications.
@nl
type
label
Cancer DNA methylation: molecular mechanisms and clinical implications.
@en
Cancer DNA methylation: molecular mechanisms and clinical implications.
@nl
prefLabel
Cancer DNA methylation: molecular mechanisms and clinical implications.
@en
Cancer DNA methylation: molecular mechanisms and clinical implications.
@nl
P2860
P1476
Cancer DNA methylation: molecular mechanisms and clinical implications.
@en
P2093
Michael T McCabe
Paula M Vertino
P2860
P304
P356
10.1158/1078-0432.CCR-08-2784
P407
P577
2009-06-09T00:00:00Z